Results 1 to 10 of about 251,978 (341)

Idiopathic inflammatory myopathies lack neutralising autoantibodies to type- I, II and III interferons [PDF]

open access: yesRMD Open
Objective To determine whether autoantibodies against interferons are present and play a role in disease modulation in idiopathic inflammatory myopathies (IIMs).Methods We screened for autoantibodies against a large number of interferons (IFNs) and other
Ingrid Lundberg   +6 more
doaj   +2 more sources

Association of Neuronal Autoantibodies with Overall Survival in Patients with Gastric Cancer. [PDF]

open access: goldCancer Res Commun
Liu G   +9 more
europepmc   +2 more sources

VEGF controls microglial phagocytic response to amyloid-β

open access: yesFrontiers in Cellular Neuroscience, 2023
Microglial cells are well known to be implicated in the pathogenesis of Alzheimer’s disease (AD), due to the impaired clearance of amyloid-β (Aβ) protein.
Priscille de Gea   +9 more
doaj   +1 more source

Conformation-stabilizing ELISA and cell-based assays reveal patient subgroups targeting three different epitopes of AGO1 antibodies

open access: yesFrontiers in Immunology, 2022
Autoantibodies (Abs) are biomarkers for many disease conditions and are increasingly used to facilitate diagnosis and treatment decisions. To guarantee high sensitivity and specificity, the choice of their detection method is crucial.
Christian P. Moritz   +29 more
doaj   +1 more source

Autoantibodies against complement factor B in rheumatoid arthritis

open access: yesFrontiers in Immunology, 2023
Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disorder affecting the joints. Many patients carry anti-citrullinated protein autoantibodies (ACPA).
Alexandra T. Matola   +12 more
doaj   +1 more source

Flow cytofluorimetric analysis of anti-LRP4 (LDL receptor-related protein 4) autoantibodies in Italian patients with Myasthenia gravis [PDF]

open access: yes, 2015
Background: Myasthenia gravis (MG) is an autoimmune disease in which 90% of patients have autoanti-bodies against the muscle nicotinic acetylcholine receptor (AChR), while autoantibodies to muscle-specific tyrosine kinase (MuSK) have been detected in ...
Antonini, Giovanni   +11 more
core   +12 more sources

Autoantibodies predict type 1 diabetes after gestational diabetes – a 23-year cohort study

open access: yesFrontiers in Endocrinology, 2023
ObjectiveTo study the predictive value of autoantibodies for type 1 (T1DM) and type 2 (T2DM) diabetes morbidity after gestational diabetes (GDM) in a 23-year follow-up study.DesignProspective population-based cohort study.MethodsWe studied 391 women with
Kaisu Luiro   +13 more
doaj   +1 more source

The significance of preclinical anti-BP180 autoantibodies

open access: yesFrontiers in Immunology, 2022
Bullous pemphigoid (BP) is the most common autoimmune subepidermal blistering disease. Although the pathomechanism of BP onset has yet to be elucidated in detail, BP autoantibodies targeting two hemidesmosomal components, BP180 and BP230, are known to ...
Yosuke Mai   +3 more
doaj   +1 more source

Immunoglobulin E and G autoantibodies against eosinophil proteins in children and adults with asthma and healthy subjects

open access: yesWorld Allergy Organization Journal, 2023
Background: Autoimmune IgG response has been described in the pathogenesis of asthma in adults, but IgE autoimmunity has been little explored. Considering high levels of blood eosinophils and immunoglobulin E in asthmatic patients, the possibility of IgE
Jorge Sánchez, MD, MSc, EAC, PhD   +4 more
doaj   +1 more source

Affinity purification of serum-derived anti-IA-2 autoantibodies in type 1 diabetes using a novel MBP-IA-2 fusion protein

open access: yesBiochemistry and Biophysics Reports, 2023
Autoantibodies targeting epitopes contained within the intracellular domain (IC) of the protein phosphatase-like islet antigen 2 (IA-2) are a common marker of autoimmune type 1 diabetes (T1D), however the isolation of genuine, serum derived anti-IA-2 ...
Thilini Mendis   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy